Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-06-24

Clinical Trial Update: C1-inhibitor in Allergic ASThma Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for C1-inhibitor in allergic asthma patients has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • C1-inhibitor

Snippet

Sponsor: T. van der Poll | Conditions: Asthma | Phase 4 | Status: TERMINATED